Two-year abrocitinib in atopic dermatitis: Are we reaching the new targets?

Axel De Greef1,2, Marie Baeck1,2

  • 1Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Abstract

No abstract available in PubMed .